Pulmokine, Inc. SBIR Phase I Award, April 2017
A SBIR Phase I contract was awarded to Pulmokine in April, 2017 for $515,573.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
515,573
0
Date Awarded
April 1, 2017
0
End Date
September 30, 2019
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43HL135910-01A1
0
Award Phase
Phase I
0
Award Type
SBIR
0
Official Website
Find more entities like Pulmokine, Inc. SBIR Phase I Award, April 2017
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.